7774.T JPX
Japan Tissue Engineering Co., Ltd.
1W: -1.8%
1M: -3.6%
3M: +33.5%
YTD: +40.2%
1Y: +56.0%
3Y: +46.4%
5Y: +7.3%
¥831.00 ($5.27)
-2.00 (-0.24%)
Weekly Expected Move ±8.3%
¥695
¥764
¥833
¥902
¥971
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$6.5B
-6.8% ▼
5Y CAGR: -5.1%
Total Liabilities
$688M
-24.3% ▼
5Y CAGR: -3.5%
Shareholders Equity
$5.8B
-4.2% ▼
5Y CAGR: -5.3%
Cash & Investments
$3.9B
-8.9% ▼
5Y CAGR: -7.5%
Total Debt
$0
+0.0% ▲
Net Debt
-$3.9B
-88.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5.3B | $4.9B | $4.1B | $2.1B | $3.9B |
| Short-Term Investments | $0 | $0 | $0 | $2.2B | $0 |
| Cash & ST Investments | $5.3B | $4.9B | $4.1B | $4.3B | $3.9B |
| Net Receivables | $822M | $496M | $576M | $609M | $594M |
| Inventory | $204M | $187M | $238M | $229M | $182M |
| Other Current Assets | $190M | $252M | $231M | $204M | $133M |
| Total Current Assets | $6.5B | $5.9B | $5.2B | $5.3B | $4.8B |
| Property, Plant & Equip. | $1.6B | $1.6B | $1.6B | $1.5B | $1.4B |
| Goodwill & Intangibles | $17M | $36M | $94M | $103M | $97M |
| Long-Term Investments | $20K | $20K | $20K | $20K | $150M |
| Other Non-Current Assets | $3M | $2M | $11M | $36M | $21M |
| Total Non-Current Assets | $1.6B | $1.7B | $1.7B | $1.6B | $1.7B |
| Total Assets | $8.1B | $7.6B | $6.9B | $7.0B | $6.5B |
| — Liabilities — | |||||
| Accounts Payable | $147M | $117M | $68M | $84M | $109M |
| Short-Term Debt | $866K | $803K | $133K | $0 | $0 |
| Deferred Revenue | $560M | $479M | $551M | $82M | $40M |
| Other Current Liabilities | $37M | $122M | $49M | $510M | $336M |
| Total Current Liabilities | $919M | $897M | $911M | $874M | $637M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $35M | $35M | $35M | $35M | $51M |
| Total Non-Current Liabilities | $36M | $35M | $35M | $35M | $51M |
| Total Liabilities | $955M | $932M | $946M | $908M | $688M |
| — Equity — | |||||
| Common Stock | $5.0B | $5.0B | $5.0B | $5.0B | $5.0B |
| Retained Earnings | -$583M | -$1.1B | -$1.8B | -$1.7B | -$1.9B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $7.2B | $6.7B | $5.9B | $6.1B | $5.8B |
| Total Liabilities & Equity | $8.1B | $7.6B | $6.9B | $7.0B | $6.5B |
| — Key Metrics — | |||||
| Total Debt | $2M | $936K | $133K | $0 | $0 |
| Net Debt | -$5.3B | -$4.9B | -$4.1B | -$2.1B | -$3.9B |
| Total Investments | $20K | $20K | $20K | $2.2B | $150M |